| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Endotoxin Group and 2 Laboratory of Bacterial Envelopes and Antibiotics, Unité Mixte de Recherche-8619 of the National Center for Scientific Research, University of Paris-Sud, 91405 Orsay, France
Infection of the respiratory tract is a frequent cause of lung pathologies, morbidity, and death. When bacterial endotoxin [lipopolysaccharide (LPS)] reaches the alveolar spaces, it encounters the lipid-rich surfactant that covers the epithelium. Although binding of hydrophilic surfactant protein (SP) A and SP-D with LPS has been established, nothing has been reported to date on possible cross talks between LPS and hydrophobic SP-B and SP-C. We designed a new binding technique based on the incorporation of surfactant components to lipid vesicles and the separation of unbound from vesicle-bound LPS on a density gradient. We found that among the different hydrophobic components of mouse surfactant separated by gel filtration or reverse-phase HPLC, only SP-C exhibited the capacity to bind to a tritium-labeled LPS. The binding of LPS to vesicles containing SP-C was saturable, temperature dependent, related to the concentrations of SP-C and LPS, and inhibitable by distinct unlabeled LPSs. Unlike SP-A and SP-D, the binding of SP-C to LPS did not require calcium ions. This LPS binding capacity of SP-C may represent another antibacterial defense mechanism of the lung.
endotoxin; surfactant protein A; surfactant protein B; surfactant protein D
This article has been cited by other articles:
|
|
 |
|
  E. Ramirez, A. Santana, A. Cruz, I. Plasencia, and G. E. Lopez Molecular Dynamics of Surfactant Protein C: From Single Molecule to Heptameric Aggregates Biophys. J., April 15, 2006; 90(8): 2698 - 2705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-Z. Wu, S. Medjane, S. Chabot, F. S. Kubrusly, I. Raw, M. Chignard, and L. Touqui Surfactant Protein-A and Phosphatidylglycerol Suppress Type IIA Phospholipase A2 Synthesis via Nuclear Factor-{kappa}B Am. J. Respir. Crit. Care Med., September 15, 2003; 168(6): 692 - 699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Augusto, M. Synguelakis, Q. Espinassous, M. Lepoivre, J. Johansson, and R. Chaby Cellular Antiendotoxin Activities of Lung Surfactant Protein C in Lipid Vesicles Am. J. Respir. Crit. Care Med., August 1, 2003; 168(3): 335 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Epaud, M. Ikegami, J. A. Whitsett, A. H. Jobe, T. E. Weaver, and H. T. Akinbi Surfactant Protein B Inhibits Endotoxin-Induced Lung Inflammation Am. J. Respir. Cell Mol. Biol., March 1, 2003; 28(3): 373 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Casals, J. Arias-Diaz, F. Valino, A. Saenz, C. Garcia, J. L. Balibrea, and E. Vara Surfactant strengthens the inhibitory effect of C-reactive protein on human lung macrophage cytokine release Am J Physiol Lung Cell Mol Physiol, March 1, 2003; 284(3): L466 - L472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Augusto, M. Synguelakis, J. Johansson, T. Pedron, R. Girard, and R. Chaby Interaction of Pulmonary Surfactant Protein C with CD14 and Lipopolysaccharide Infect. Immun., January 1, 2003; 71(1): 61 - 67. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
